Latest news
Loading news…
Origen Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Burlingame, California, United States Founded 1997 11-50 employees For Profit
Origen Therapeutics develops therapeutic products from avian transgenic animal technology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 5
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing
- IT spend
- $9M
Company Info
- Founded
- 1997
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 2
- HQ
- Burlingame, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Closed
- Apr 1, 2014
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- 2.1
- Trend (90d)
- 3.8
1
professional contacts at Origen Therapeutics
Contact execs at Origen Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Origen Therapeutics
Loading news…
FAQs about Origen Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.